Etanercept Ameliorates Vascular, Endocrine, and Ovarian Changes in a Rat Model of DHEA-Induced Polycystic Ovary Syndrome

ZE Utkan Korun, SS Gocmez, S Furat Rencber… - Reproductive …, 2024 - Springer
Polycystic ovary syndrome (PCOS) is a metabolic and endocrine disorder affecting women
of reproductive age. This study examined the efficacy of etanercept (ETA), an anti-TNF-α …

Etanercept Ameliorates Vascular, Endocrine, and Ovarian Changes in a Rat Model of DHEA-Induced Polycystic Ovary Syndrome

Z Utkan Korun, S GÖÇMEZ… - REPRODUCTIVE …, 2024 - avesis.kocaeli.edu.tr
Polycystic ovary syndrome (PCOS) is a metabolic and endocrine disorder affecting women
of reproductive age. This study examined the efficacy of etanercept (ETA), an anti-TNF-alpha …

Etanercept Ameliorates Vascular, Endocrine, and Ovarian Changes in a Rat Model of DHEA-Induced Polycystic Ovary Syndrome.

UK ZE, SS Gocmez, FC Eraldemir… - … (Thousand Oaks, Calif.), 2023 - europepmc.org
Polycystic ovary syndrome (PCOS) is a metabolic and endocrine disorder affecting women
of reproductive age. This study examined the efficacy of etanercept (ETA), an anti-TNF-α …

Etanercept Ameliorates Vascular, Endocrine, and Ovarian Changes in a Rat Model of DHEA-Induced Polycystic Ovary Syndrome

ZEU Korun, SS Gocmez, SF Rencber… - Reproductive …, 2024 - pubmed.ncbi.nlm.nih.gov
Polycystic ovary syndrome (PCOS) is a metabolic and endocrine disorder affecting women
of reproductive age. This study examined the efficacy of etanercept (ETA), an anti-TNF-α …